Interest in cocoa has moved beyond desserts and into serious nutrition research, especially as scientists look for simple ways to support heart health. Cocoa supplements concentrate flavanols, natural compounds that help blood vessels relax and improve circulation. This has made them a focus of new studies exploring how small daily habits may influence long-term cardiovascular outcomes.
Researchers found that adults who took a daily cocoa flavanol supplement had a significantly lower risk of dying from heart disease compared with those who took a placebo. The reduction was about 27 percent over several years of follow-up. While experts caution that supplements cannot replace a healthy diet, the findings suggest cocoa flavanols may play a meaningful role in protecting the heart.
The big trial behind the headlines (COSMOS)
The Cocoa Supplement and Multivitamin Outcomes Study, known as COSMOS, was led by investigators at Brigham and Women’s Hospital and Harvard Medical School. It followed more than 21,000 older U.S. adults for a median of 3.6 years.
Participants were randomized to receive either 500 milligrams per day of cocoa flavanols or a placebo. This intervention was layered onto otherwise typical medical care in an aging population already benefiting from statins and blood pressure drugs.
Results from the COSMOS randomized trial showed that cocoa supplementation did not significantly reduce the primary endpoint of total cardiovascular events. The hazard ratio was 0.90, with a 95 percent confidence interval of 0.78 to 1.02. Yet within those same data, cardiovascular death emerged as a notable exception, declining by 27 percent as a prespecified secondary outcome.
27 percent lower risk of dying from cardiovascular causes
Across the full COSMOS cohort, researchers documented 180 cardiovascular deaths during follow-up. When outcomes were compared between groups, those assigned to cocoa extract experienced a hazard ratio of 0.73 for cardiovascular death relative to placebo. The 95 percent confidence interval ranged from 0.54 to 0.98, crossing the threshold of statistical significance.
In the primary COSMOS paper, investigators explicitly described this finding as a statistically significant 27 percent reduction in cardiovascular mortality. The nuance mattered. Heart attacks and strokes taken together did not fall enough to meet the trial’s main endpoint. The mortality signal suggested that cocoa flavanols might influence the deadliest outcomes even when event counts stayed similar.
Possible drop in heart attacks and strokes in on-protocol users
The intention-to-treat analysis in COSMOS, which counts everyone according to their original assignment, showed no statistically significant reduction in total cardiovascular events. That conservative approach reflects real-world behavior, including missed doses and dropouts, and it set the official headline result of the trial.
When investigators examined per-protocol analyses limited to participants who took the cocoa supplements as directed, a different pattern appeared. In that analysis, cocoa extract was associated with a hazard ratio of 0.84 for major cardiovascular events, including heart attack, stroke, and cardiovascular death. The 95 percent confidence interval ranged from 0.71 to 0.99, hinting that adherence may shape benefit.
How cocoa flavanols appear to help your arteries
Cocoa is unusually rich in flavanols such as epicatechin and proanthocyanidins, compounds long studied for their vascular effects. Controlled feeding trials conducted at institutions including the University of Reading and the German Institute of Human Nutrition have shown that these molecules improve endothelial function. This is a measure of how effectively blood vessels relax and widen.
One randomized trial in healthy adults, published in the American Journal of Clinical Nutrition, tested 450 milligrams of cocoa flavanols taken twice daily. Researchers reported improved flow-mediated dilation of arteries alongside reductions in estimated ten-year Framingham risk scores for coronary heart disease and overall cardiovascular disease. This linked molecular effects to established clinical risk models.
Small but meaningful shifts in blood pressure and cholesterol
Beyond single trials, broader patterns emerge from pooled evidence. A 2024 meta-analysis of randomized controlled trials published in Nutrients evaluated cocoa and flavanol intake among adults at cardiovascular risk. It found modest but consistent reductions in blood pressure, improvements in insulin resistance, and decreases in LDL and total cholesterol.
The authors of that 2024 meta-analysis concluded that cocoa consumption led to overall improvements in cardiometabolic markers, including lipids, glycemic control, and blood pressure. They framed cocoa not as a cure but as a vascular tune-up, capable of nudging multiple risk factors in a favorable direction when added to standard prevention strategies.
Emerging evidence around heart function and remodeling
More recent mechanistic trials have begun to look beyond arteries to the heart itself. Research teams studying early diastolic dysfunction have tested whether cocoa flavanols influence subtle structural changes. These include enlargement of the left atrium and ventricle that often precede symptomatic heart failure.
In one randomized trial focused on cardiac imaging outcomes, flavanol supplementation reduced left atrial volume and improved measures of diastolic filling. These shifts in cardiac remodeling offer a plausible biological pathway. They could help explain why lower cardiovascular mortality emerged in large outcome trials like COSMOS, even without dramatic drops in event counts.
Why supplements are not the same as eating chocolate bars
The cocoa extract used in COSMOS delivered 500 milligrams of flavanols per day, including roughly 80 milligrams of epicatechin. Nutrition scientists note that this dose is difficult to reach through everyday chocolate consumption, particularly with standard milk chocolate. Reaching it would also require consuming large amounts of sugar and saturated fat.
Reviews from organizations such as the European Food Safety Authority emphasize that many commercial chocolates are heavily processed and depleted of flavanols. Treating candy as a health supplement risks offsetting potential vascular benefits with metabolic harm. This underscores why researchers distinguish purified flavanol supplements from dessert foods.
Experts frame cocoa as an add-on, not a substitute
In their published conclusions, COSMOS investigators were careful with language. They stated that cocoa extract did not significantly reduce the total number of cardiovascular events. They also emphasized the need for longer follow-up and additional trials before recommending routine supplementation for the general population.
Cardiovascular prevention experts echo that restraint. Commentaries in journals such as Circulation emphasize that cocoa flavanols should complement, not replace, proven interventions. These include blood pressure control, statin therapy when indicated, smoking cessation, and regular physical activity. All of these deliver benefits far larger than any single supplement.
The real-world angle in an aging population
COSMOS was designed to detect an 11 percent reduction in total cardiovascular disease. It enrolled predominantly older adults at a time when preventive care had already improved outcomes. Many participants were already taking statins, antihypertensives, and aspirin, raising the bar for any additional intervention to show benefit.
Against that backdrop, the observed 27 percent reduction in cardiovascular death stands out. It emerged not in an untreated population, but layered on top of modern standard care. This suggests that cocoa flavanols may exert incremental protection even when baseline risk is already being actively managed.
Key Takeaway
Cocoa supplements are now one of the few chocolate-adjacent habits with randomized trial data. These data hint at real protection against heart disease and cardiovascular death.
Disclaimer – This list is solely the author’s opinion based on research and publicly available information. It is not intended to be professional advice.
Like our content? Be sure to follow us
